Hassan Khalil | Medical Discoveries | Innovative Research Award

Published on by Scientist Day

Global Scientist Day Awards

Hassan Khalil
Affiliation Harvard Medical School
Country United States
Scopus ID 55910803200
Documents 51
Citations 834
h-index 16
Subject Area Medical Discoveries
Event Global Scientist Day Awards
ORCID 0000-0002-3835-1290

Hassan Khalil is a researcher affiliated with Harvard Medical School in the United States whose scholarly profile is associated with the subject area of Medical Discoveries. The supplied bibliographic profile records 51 documents, 834 citations, and an h-index of 16 in Scopus under author identifier 55910803200. His ORCID record provides an additional persistent identifier for distinguishing the researcher within scholarly communication systems. [1] [2]

Abstract

Hassan Khalil is presented in this academic recognition profile as a researcher affiliated with Harvard Medical School in the United States and associated with the subject area of Medical Discoveries. The supplied bibliometric record identifies Scopus Author ID 55910803200 and reports 51 documents, 834 citations, and an h-index of 16. These indicators provide a quantitative description of indexed research activity and citation impact.[1] [2]

Keywords

Hassan Khalil, Harvard Medical School, Medical Discoveries, biomedical research, medical research, scientific publications, research impact, Scopus, ORCID, citation analysis, h-index, Global Scientist Day Awards.

Introduction

Academic recognition frequently incorporates both qualitative examination of scholarly contributions and quantitative indicators derived from bibliographic databases. Scopus provides author-level information that can assist in examining publication and citation activity, while ORCID provides a persistent identifier designed to distinguish researchers with similar or identical names. [1] [2]

Research Profile

The supplied research profile associates Hassan Khalil with Harvard Medical School and the broader field of Medical Discoveries. The reported bibliometric record contains 51 documents and 834 citations, with an h-index of 16. These values are presented as supplied profile data and may change as bibliographic databases are updated, corrected, or expanded. Scopus author records can also require author-disambiguation review when researchers share similar names or when publications are assigned to an author profile over time. [1][2]

Research Contributions

The available information supports describing Hassan Khalil’s research activity through the documented publication and citation indicators associated with the supplied profile. A record of 51 documents indicates a body of indexed scholarly output, while 834 citations indicate that publications attributed to the profile have been cited within the relevant indexed literature. The h-index of 16 reflects the distribution of citations across publications according to the conventional h-index methodology. [3]

Publications

The supplied profile reports 51 Scopus-indexed documents associated with Author ID 55910803200. Because individual publication titles, journal details, publication years, and DOI identifiers were not supplied in the source information for this article, no specific publication-level claims are made here. The Scopus author profile provides the appropriate location for reviewing the indexed document record and verifying individual publications. [1] [3]

Research Impact

The supplied citation count of 834 and h-index of 16 provide quantitative indicators of the visibility of the researcher’s indexed publications. Citation metrics are commonly used as descriptive bibliometric measures, but their interpretation depends on field, publication age, database coverage, and citation practices. [3]

Award Suitability

For the Global Scientist Day Awards, the supplied profile contains several forms of information commonly used to document an academic research record, including institutional affiliation, subject area, publication count, citation count, h-index, Scopus identification, and ORCID identification. These details can support administrative verification and bibliographic review. [4]

Conclusion

Hassan Khalil’s supplied academic profile identifies an affiliation with Harvard Medical School and a research focus described as Medical Discoveries. The associated Scopus information reports 51 documents, 834 citations, and an h-index of 16, while the ORCID identifier provides an additional persistent mechanism for researcher identification.

References

    1. Elsevier. (2026.). Scopus author details: Hassan Khalil, Author ID 55910803200. Scopus.
      https://www.scopus.com/authid/detail.uri?authorId=55910803200
    2. ORCID. (2026.). Hassan Khalil — ORCID record. ORCID.
      https://orcid.org/0000-0002-3835-1290
    3. Perioperative Risk and Modifiable Targets in Sequential Pulmonary Resection Within One Year.
      https://www.mdpi.com/2077-0383/15/18/7252
    4. Global Scientist Day Awards. (2026.). Global Scientist Day Awards.
      https://scientistday.org/

Paul Poirier | Precision Medicine | Best Researcher Award

Published on by Scientist Day

Global Scientist Day Awards

Paul Poirier
Quebec University Institute of Cardiology and Pulmonology

Paul Poirier
Affiliation Quebec University Institute of Cardiology and Pulmonology
Country Canada
Scopus ID 7006516211
Documents 473
Citations 35,166
h-index 74
Subject Area Precision Medicine
Event Global Scientist Day Awards
ORCID 0000-0002-5395-3273

Paul Poirier is a Canadian physician-scientist whose academic career has been dedicated to advancing cardiovascular medicine, obesity research, metabolic health, preventive cardiology, and precision medicine. Through extensive clinical investigation, interdisciplinary collaboration, and evidence-based practice, he has contributed substantially to understanding the interactions between cardiovascular disease, diabetes, obesity, and lifestyle interventions. His scholarly productivity and international recognition have established him as an influential researcher in cardiovascular sciences.[1]

Abstract

Paul Poirier’s research portfolio integrates clinical cardiology with precision medicine by investigating cardiovascular risk factors associated with obesity, diabetes, metabolic syndrome, exercise physiology, and preventive healthcare. His publications have significantly contributed to clinical guidelines and multidisciplinary patient management while supporting personalized therapeutic strategies across cardiovascular medicine.[1]

Keywords

Precision Medicine, Preventive Cardiology, Obesity, Cardiovascular Disease, Exercise Physiology, Diabetes, Metabolic Syndrome, Lifestyle Medicine, Clinical Research, Cardiometabolic Health.

Introduction

The increasing prevalence of obesity and metabolic disorders has emphasized the importance of precision medicine approaches in cardiovascular healthcare. Paul Poirier has played an active role in addressing these challenges through research focusing on individualized risk assessment, lifestyle modification, and evidence-based cardiovascular prevention. His work has strengthened the scientific understanding of cardiometabolic interactions and clinical management strategies.[2]

Research Profile

With more than 470 indexed scientific publications, over 35,000 citations, and an h-index of 74, Paul Poirier has established an internationally recognized research profile. His investigations encompass cardiovascular physiology, obesity medicine, diabetes management, preventive cardiology, clinical epidemiology, and precision healthcare. He has collaborated with numerous international institutions and contributed to major scientific consensus documents and clinical recommendations.[1]

Research Impact

The scientific influence of Paul Poirier is reflected through extensive citations, sustained publication output, international collaborations, and contributions to clinical practice recommendations. His work has enhanced evidence-based cardiovascular prevention and informed healthcare professionals regarding obesity-associated cardiovascular risk and precision therapeutic interventions.[3]

Award Suitability

Paul Poirier demonstrates characteristics associated with distinguished scientific achievement through sustained publication productivity, extensive scholarly influence, international collaboration, and meaningful contributions to cardiovascular medicine and precision healthcare. His research aligns with the objectives of the Global Scientist Day Awards by promoting scientific excellence, clinical innovation, and measurable improvements in patient care and public health.[1]

Conclusion

Paul Poirier has developed an internationally respected academic profile through impactful research in cardiovascular medicine, obesity, metabolic health, and precision medicine. His sustained scientific contributions continue to influence clinical practice, research collaborations, and evidence-based healthcare, making his work highly relevant within the international scientific community.

References

  1. Elsevier (2026). Scopus author details: Paul Poirier, Author ID 7006516211. Scopus.
    https://www.scopus.com/pages/authors/7006516211
  2. Pre-exercise meal macronutrient composition and acute inflammatory response in males with type 2 diabetes mellitus.
    https://doi.org/10.1161/CIRCULATIONAHA.106.171016
  3. ORCID (2026). Paul Poirier ORCID Profile.
    https://orcid.org/0000-0002-5395-3273

Sallysamir Zahran | Drug Development | Best Researcher Award

Published on by Scientist Day

Global Scientist Day Awards

Sallysamir Zahran
Affiliation Egyptian Atomic Energy Authority
Country Egypt
Scopus ID 56490517500
Documents 5
Citations 116
h-index 3
Subject Area Drug Development
Event Global Scientist Day Awards

Sallysamir Zahran

Institution: Egyptian Atomic Energy Authority
Country: Egypt

Sallysamir Zahran is associated with the Egyptian Atomic Energy Authority and contributes to scientific research in the interdisciplinary field of drug development. Research activities have focused on developing innovative pharmaceutical and biomedical solutions supported by experimental investigations and collaborative scientific approaches. Scholarly publications indexed in Scopus demonstrate sustained academic engagement and measurable citation impact within the international research community.[1]

Abstract

Drug development requires integration of pharmaceutical science, biomedical research, analytical methodologies, and translational innovation. Sallysamir Zahran’s scholarly work contributes to these objectives through research that supports improved therapeutic strategies and scientific understanding. The publication record indexed by Scopus reflects consistent scientific productivity, while citation metrics indicate that the research has been referenced by fellow investigators within related disciplines.[1]

Keywords

Drug Development, Pharmaceutical Sciences, Biomedical Research, Therapeutic Innovation, Drug Discovery, Translational Medicine, Experimental Pharmacology, Clinical Research, Medical Science, Scientific Publications

Introduction

Modern drug development combines chemistry, biology, pharmacology, toxicology, and clinical science to produce safe and effective therapeutic interventions. Researchers working within this multidisciplinary environment contribute to improving healthcare outcomes through systematic experimentation, validation, and scientific communication. Publications indexed by international databases such as Scopus provide evidence of research visibility and scholarly dissemination.[1]

Research Profile

Sallysamir Zahran is affiliated with the Egyptian Atomic Energy Authority and has established an academic profile within the field of drug development. According to the available Scopus author profile, the researcher has produced five indexed scholarly documents, accumulated 116 citations, and attained an h-index of 3. These indicators demonstrate measurable scientific engagement and continued participation in internationally indexed research activities.[1]

Research Contributions

The research contributions emphasize experimental investigations supporting pharmaceutical innovation and biomedical applications. Published studies contribute to scientific knowledge related to therapeutic development, laboratory evaluation, and evidence-based research methodologies. Collaborative investigations further strengthen interdisciplinary knowledge exchange while encouraging reproducibility and scientific transparency.[2]

Publications

Research publications indexed within Scopus demonstrate scholarly dissemination in drug development and associated biomedical sciences. These publications collectively contribute to scientific literature through experimental evidence and peer-reviewed communication. Representative research articles include publications with Digital Object Identifiers (DOIs), enabling persistent scholarly access.[2]

Research Impact

Citation-based indicators provide evidence that the published research has received attention from the broader scientific community. The available Scopus metrics indicate 116 citations across five indexed documents with an h-index of 3, reflecting measurable academic influence and continued relevance within drug development research.[1]

Award Suitability

Based on the available scholarly indicators, Sallysamir Zahran demonstrates characteristics commonly associated with academic recognition, including peer-reviewed publications, international indexing, measurable citation performance, and contributions to drug development research. The research portfolio aligns with the objectives of the Global Scientist Day Awards, which recognize scientific excellence, innovation, and continued advancement of research across diverse disciplines.[3]

Conclusion

Sallysamir Zahran has established a recognized research profile within the field of drug development through scholarly publications, citation impact, and international indexing. The documented research activities contribute to scientific knowledge while supporting continued innovation in pharmaceutical and biomedical sciences. The available academic record reflects meaningful participation in global research and represents a profile suitable for consideration within international scientific recognition programs.[1]

References

  1. Elsevier. (2026). Scopus Author Details: Sallysamir Zahran, Author ID 56490517500. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=56490517500
  2. Novel pyrrole-sulfonamide derivatives as EGFR inhibitors and radiosensitizers in lung cancer.
    http://10.1016/j.bioorg.2025.109173
  3. Global Scientist Day Awards. (2026). Official Award Website.
    https://scientistday.org/

Marko Radulovic | Precision Medicine | Research Excellence Award

Published on by Scientist Day

Research Excellence Award – Marko Radulovic

Marko Radulovic

Institute for Oncology and Radiology, Serbia

Marko Radulovic
Affiliation Institute for Oncology and Radiology
Country Serbia
Scholar ID 9GWuJvAAAAAJ
Documents 91
Citations 2,347
h-index 25
Subject Area Precision Medicine
Event Global Scientist Day Awards

Marko Radulovic of the Institute for Oncology and Radiology, Serbia, has established a notable academic profile through extensive research activity, a substantial publication record, and significant citation impact within the field of Precision Medicine.[1] His body of work reflects continued engagement with translational and clinical research aimed at improving healthcare outcomes through evidence-based scientific inquiry.[2]

Abstract

This article presents an academic recognition profile of Marko Radulovic in consideration for the Research Excellence Award. The assessment is based on publicly available scholarly indicators, including publication productivity, citation performance, research influence, and disciplinary engagement in Precision Medicine. With 91 indexed scholarly documents, 2,347 citations, and an h-index of 25, his academic record demonstrates sustained scientific contribution and measurable impact within oncology-related and precision healthcare research domains.[1]

Keywords

Precision Medicine; Oncology Research; Clinical Translation; Cancer Studies; Research Excellence Award; Scientific Impact; Citation Analysis; Healthcare Innovation.

Introduction

Precision Medicine has emerged as a transformative area of modern healthcare by integrating molecular biology, clinical diagnostics, and patient-specific therapeutic strategies. Researchers operating within this field contribute to the development of individualized treatment approaches that improve clinical outcomes and optimize healthcare resources.[3] Marko Radulovic’s research activities align with these objectives through scholarly work that supports evidence-based advancement in cancer diagnosis, treatment optimization, and translational medicine.[2]

Research Profile

Marko Radulovic is affiliated with the Institute for Oncology and Radiology in Serbia, an institution recognized for its involvement in cancer research and clinical care. His scholarly profile demonstrates sustained participation in scientific publishing and multidisciplinary collaboration. The available bibliometric indicators suggest broad engagement with the international scientific community and a consistent record of knowledge dissemination.[1]

  • Affiliation: Institute for Oncology and Radiology
  • Country: Serbia
  • Subject Area: Precision Medicine
  • Documents: 91
  • Citations: 2,347
  • h-index: 25

Research Contributions

The scientific contributions associated with Marko Radulovic encompass areas relevant to oncology, personalized treatment strategies, clinical research methodologies, and translational medicine. His work contributes to the understanding of disease mechanisms and supports the integration of scientific discoveries into healthcare practice.[2]

  • Advancement of precision-based clinical approaches.
  • Contribution to oncology-related scientific literature.
  • Support for evidence-driven patient management strategies.
  • Participation in collaborative and multidisciplinary research initiatives.
  • Dissemination of findings through peer-reviewed scholarly publications.

Publications

The research portfolio of Marko Radulovic includes 91 scholarly documents indexed through major academic databases. These publications collectively contribute to the advancement of knowledge in precision medicine and oncology-related disciplines.[1]

  1. Peer-reviewed research articles.
  2. Clinical and translational research studies.
  3. Collaborative multidisciplinary publications.
  4. Scientific communications addressing precision healthcare challenges.

Research Impact

Research impact may be assessed through scholarly visibility, citation performance, and influence on subsequent investigations. With 2,347 citations and an h-index of 25, Marko Radulovic’s work has demonstrated measurable recognition within the scientific community.[1] These indicators suggest that his publications have contributed to ongoing academic discourse and have informed related areas of biomedical research.[2]

Award Suitability

Based on available academic metrics and evidence of sustained scholarly activity, Marko Radulovic demonstrates characteristics commonly associated with candidates for research recognition programs. His publication record, citation influence, and contributions to precision medicine collectively support consideration for the Research Excellence Award. The combination of productivity, scientific impact, and disciplinary relevance reflects a mature and influential research profile.[1]

Conclusion

Marko Radulovic has developed a substantial academic record within the field of Precision Medicine through sustained research productivity and scholarly engagement. His documented achievements, publication output, and citation impact provide evidence of meaningful scientific contribution. These accomplishments align with the objectives of the Global Scientist Day Awards and support recognition through the Research Excellence Award.[1]

References

  1. Google Scholar. (n.d.). Marko Radulovic Citation Profile and Scholarly Metrics. Google Scholar. https://scholar.google.com/citations?user=9GWuJvAAAAAJ&hl=en&oi=ao
  2. Discriminative Pattern Mining for Breast Cancer Histopathology Image Classification via Fully Convolutional Autoencoder.
    https://ieeexplore.ieee.org/abstract/document/8664469
  3. Pharmacology and Biology of Corticotropin-Releasing Factor (CRF) Receptors.
    https://www.tandfonline.com/doi/abs/10.3109/10606820213678
  4. Corticotropin-Releasing Factor Receptor 1 in Mouse Spleen: Expression After Immune Stimulation and Identification of Receptor-Bearing Cells. https://academic.oup.com/jimmunol/article-abstract/162/5/3013/8041238

Taeyoung Kyong | Medical Discoveries | Research Excellence Award

Published on by Scientist Day

Prof. Taeyoung Kyong | Medical Discoveries | Research Excellence Award

Yonsei University College of Medicine | South Korea

Professor Taeyoung Kyong is a distinguished hospitalist and academic at Yonsei University College of Medicine, specializing in internal medicine and diabetes care. His work focuses on hospitalist-led care models that enhance glycemic control, patient safety, and care transitions in inpatient settings. He has led and contributed to impactful clinical research, published extensively in indexed journals, and served as a reviewer for international medical journals. Through collaborations with leading hospitals and medical technology firms, he integrates digital health and AI-driven monitoring into clinical practice, advancing evidence-based hospital medicine and improving outcomes for patients with chronic diseases.
View Orcid Profile

Featured Publications

Ahsan Khan | Biomedical Engineering | Research Excellence Award

Published on by Scientist Day

Dr. Ahsan Khan | Biomedical Engineering | Research Excellence Award

Dr. Ahsan Khan | Tongji University | China

Dr. Ahsan Riaz Khan is an accomplished researcher specializing in chemical engineering, environmental sciences, corrosion science, surface engineering, and biomaterials. He holds advanced academic qualifications in Chemical Engineering and Environmental Sciences, complemented by strong interdisciplinary training across materials development, environmental health, and biomedical applications. He is currently serving as a Postdoctoral Researcher at the School of Medicine, Tongji University, Shanghai, where he contributes to cutting-edge research on biomaterials, corrosion-resistant surfaces, biocompatibility, drug-release systems, and in-vivo/in-vitro implant evaluations. Dr. Khan’s research expertise spans the development of novel, sustainable, and cost-effective coating materials; surface modification of metals and alloys; tribology; anticorrosion technology; adhesion engineering; electrochemical methods; and advanced techniques in cell culture, toxicity analysis, and immunohistochemistry. His interdisciplinary background enables him to work at the intersection of engineering, materials science, medicine, and environmental sustainability. He has published 28 peer-reviewed research papers, contributing significantly to high-impact journals in materials science, corrosion protection, biomaterials, environmental pollution, electrochemistry, and regenerative medicine. His publications have received over 330 citations with an H-index above 10, reflecting strong academic influence and global research engagement. His work includes notable contributions to magnesium alloys, smart scaffolds, hybrid biomaterials, environmental risk assessments, supercapacitive materials, and psychological health investigations. Dr. Khan has earned multiple academic honors, including innovation awards, competitive scholarships, excellence certificates, and internship recognitions. He has participated in a wide range of international conferences, workshops, and training programs in environmental management, materials engineering, GIS, chemical engineering, and waste management. Skilled in a broad array of analytical and characterization techniques—such as SEM, TEM, XPS, XRD, TGA, ICP-OES, GC-MS, Raman spectroscopy, and electrochemical workstations—Dr. Khan combines technical depth with strong research leadership. Fluent in English, Urdu, and conversational Chinese (HSK-3), he remains committed to advancing global research in materials innovation, corrosion engineering, environmental sustainability, and biomedical technology.

Profile: Google Scholar

Featured Publications

Khan, A. R., Grewal, N. S., Zhou, C., Yuan, K., Zhang, H. J., & Jun, Z. Recent advances in biodegradable metals for implant applications: Exploring in vivo and in vitro responses. Results in Engineering, 20, 101526.

Zafar, Z., Mehmood, M. S., Ahamad, M. I., Chudhary, A., Abbas, N., Khan, A. R., … Trend analysis of the decadal variations of water bodies and land use/land cover through MODIS imagery: An in-depth study from Gilgit-Baltistan, Pakistan. Water Supply, 21(2), 927–940.

Rehman, A. U., Shah, M. Z., Ali, A., Zhao, T., Shah, R., Ullah, I., Bilal, H., Khan, A. R., … Thermochemical heat storage ability of ZnSO₄·7H₂O as potential long-term heat storage material. International Journal of Energy Research, 45(3), 4746–4754.

Khan, M., Tiehu, L., Hussain, A., Raza, A., Zada, A., Alei, D., Khan, A. R., Ali, R., … Physiochemical evaluations, mechanical attenuations and thermal stability of graphene nanosheets and functionalized nanodiamonds loaded pitch-derived carbon foam composites. Diamond and Related Materials, 126, 109077.

Khan, Z. U., Razzaq, A., Khan, A., Rehman, N. U., Khan, H., Khan, T., Khan, A. U., … Physicochemical characterizations and pharmacokinetic evaluation of pentazocine solid lipid nanoparticles against inflammatory pain model. Pharmaceutics, 14(2), 409.

Sylvia Mangani | Medical Discoveries | Best Researcher Award

Published on by Scientist Day

Ms. Sylvia Mangani | Medical Discoveries | Best Researcher Award

Ms. Sylvia Mangani | University of Patras | Greece

Sylvia Mangani is a biochemist–biotechnologist and PhD candidate in Biochemistry at the University of Patras, whose research centers on cancer biology, particularly the influence of the extracellular matrix on tumor growth and regulation through 3D cell culture systems. Her academic journey combines strong foundations in biochemistry and biotechnology (BSc, MSc) with advanced experimental and analytical expertise. Her work integrates a broad range of molecular and cellular biology techniques, including quantitative PCR, Western blotting, immunofluorescence, functional assays, and RNA sequencing, complemented by bioinformatics analysis for gene expression and signaling pathway interpretation. Her research has significantly contributed to understanding how 3D cellular microenvironments influence cancer progression, focusing on breast cancer models. She has authored 12 peer-reviewed publications in recognized international journals, with her work cited over 55 times according to Google Scholar, reflecting growing recognition within the scientific community. Her contributions have also supported award-winning synthetic biology initiatives under the iGEM program and have been presented at national and international scientific conferences. She has established productive collaborations with prominent research institutions in Greece and abroad. Notably, she completed a funded Erasmus+ research placement at the University Hospital of Münster, Germany, under the supervision of Prof. Martin Götte, where she engaged in experimental oncology projects exploring cancer cell behavior and matrix interactions. She has also collaborated with the National and Kapodistrian University of Athens on biochemical and molecular analyses within the Laboratory of Biochemistry, Biotechnology, and Molecular Analysis. A member of the Hellenic Society of Biochemistry and Molecular Biology (HSBMB), she actively contributes to the advancement of biochemical and cancer research in Greece and Europe. Her ongoing studies aim to deepen the understanding of tumor–matrix dynamics in breast cancer, offering new insights for therapeutic innovation and cancer model development, positioning her among emerging researchers in molecular oncology.

Profiles: Orcid | Google Scholar | LinkedIn | Research Gate

Featured Publications 

Mangani, S., Piperigkou, Z., Mangani, S., Koletsis, N. E., Koutsakis, C., Mastronikolis, N. S., Franchi, M., & Karamanos, N. K. (2025, August). Principal mechanisms of extracellular matrix‐mediated cell–cell communication in physiological and tumor microenvironments. The FEBS Journal. https://doi.org/10.1111/febs.70207

Mangani, S., Vetoulas, M., Mineschou, K., Spanopoulos, K., Vivanco, M. d. M., Piperigkou, Z., & Karamanos, N. K. (2025, July 15). Design and applications of extracellular matrix scaffolds in tissue engineering and regeneration. Cells, 14(14), 1076. https://doi.org/10.3390/cells14141076

Franchi, M., Masola, V., Onisto, M., Franchi, L., Mangani, S., Zolota, V., Piperigkou, Z., & Karamanos, N. K. (2025, July 7). Ultrastructural changes of the peri-tumoral collagen fibers and fibrils array in different stages of mammary cancer progression. Cells, 14(13), 1037. https://doi.org/10.3390/cells14131037

Karamanos, N. K., Piperigkou, Z., Gourdoupi, C., Mangani, S., & Vivanco, M. d. M. (2025, June 1). Extracellular matrix matters: Matrix-based bioscaffolds in advancing translational cancer research and targeted therapy. American Journal of Physiology-Cell Physiology, 328(6), C1235–C1251. https://doi.org/10.1152/ajpcell.00050.2025

Ciampelli, C., Mangani, S., Nieddu, G., Formato, M., Ioannou, P., Kremmydas, S., Karamanos, N., & Lepedda, A. J. (2025, March). Effects of acidic polysaccharide-enriched extracts from Holothuria tubulosa on two- and three-dimensional invasive breast cancer cell models. Biology, 14(4), 334. https://doi.org/10.3390/biology14040334

Mangani, S., Kremmydas, S., & Karamanos, N. K. (2025, March). Mimicking the complexity of solid tumors: How spheroids could advance cancer preclinical transformative approaches. Cancers, 17(7), 1161. https://doi.org/10.3390/cancers17071161

Saravanan Periasamy | Biotechnology Awards | Best Academic Researcher Award

Published on by Scientist Day

Dr. Saravanan Periasamy | Biotechnology Awards | Best Academic Researcher Award

Dr. Saravanan Periasamy | Rajalakshmi Engineering College Autonomous Chennai India | India

Dr. Saravanan Periasamy is a leading researcher in the field of biofilm science and biotechnology. He serves as an Associate Professor at the Centre of Excellence in Biofilms, Rajalakshmi Engineering College, Chennai. His research focuses on microbial biofilms, exopolysaccharide characterization, and antibiofilm therapeutics. He has completed a prestigious DST-SERB-funded project with impactful scientific outcomes. Dr. Saravanan has published over 30 research papers in reputed SCI and Scopus-indexed journals. He has also contributed five book chapters with international publishers, including CRC Press. His editorial contributions include guest editing for Frontiers in Cellular and Infection Microbiology and Frontiers in Pharmacology. He actively reviews manuscripts for major publishers such as Elsevier, Springer, and Taylor & Francis. Dr. Saravanan’s research excellence is reflected in his 4,474 citations and h-index of 19. He continues to advance innovations in microbial biotechnology through impactful research and academic leadership.

Profile: Google Scholar

Featured Publications

Kolenbrander, P. E., Palmer, R. J., Jr., Periasamy, S., & Jakubovics, N. S. (2010). Oral multispecies biofilm development and the key role of cell–cell distance. Nature Reviews Microbiology, 8(7), 471–480. https://doi.org/10.1038/nrmicro2381

Periasamy, S., Joo, H. S., Duong, A. C., Bach, T. H. L., Tan, V. Y., Chatterjee, S. S., … & Otto, M. (2012). How Staphylococcus aureus biofilms develop their characteristic structure. Proceedings of the National Academy of Sciences, 109(4), 1281–1286. https://doi.org/10.1073/pnas.1115006109

Lee, K. W. K., Periasamy, S., Mukherjee, M., Xie, C., Kjelleberg, S., & Rice, S. A. (2014). Biofilm development and enhanced stress resistance of a model, mixed-species community biofilm. The ISME Journal, 8(4), 894–907. https://doi.org/10.1038/ismej.2013.194

Periasamy, S., & Kolenbrander, P. E. (2009). Mutualistic biofilm communities develop with Porphyromonas gingivalis and initial, early, and late colonizers of enamel. Journal of Bacteriology, 191(22), 6804–6811. https://doi.org/10.1128/JB.01006-09

Periasamy, S., & Kolenbrander, P. E. (2010). Central role of the early colonizer Veillonella sp. in establishing multispecies biofilm communities with initial, middle, and late colonizers of enamel. Journal of Bacteriology, 192(12), 2965–2972. https://doi.org/10.1128/JB.01631-09

Benedetta Fantaci | Biomedical Engineering | Best Researcher Award

Published on by Scientist Day

Ms. Benedetta Fantaci | Biomedical Engineering | Best Researcher Award

Ms. Benedetta Fantaci | Universidad de Zaragoza | Spain

Dr. Benedetta Fantaci is a distinguished biomedical engineer recognized for her pioneering work in ocular biomechanics and computational modeling. Her research focuses on developing advanced corneal digital twins to enhance precision in laser refractive surgery and deepen understanding of corneal diseases like keratoconus. Through innovative finite-element opto-biomechanical simulations, she bridges the gap between engineering and ophthalmology. Her collaborative projects span several leading European institutions, addressing challenges in eye growth, vascular remodeling, and biomechanical tissue behavior. She has contributed to multiple high-impact publications and served in key scientific and organizational roles at international biomechanics conferences. Her research continues to influence global advances in vision science and biomedical innovation.

Profile: Google Scholar

Featured Publications

Fantaci, B., Calvo, B., & Rodríguez, J. F. (2024). Modeling biological growth of human keratoconus: On the effect of tissue degradation, location and size. Computers in Biology and Medicine, 180, 108976. https://doi.org/10.1016/j.compbiomed.2024.108976

Fantaci, B., Calvo, B., Barraquer, R., Picó, A., & Ariza-Gracia, M. Á. (2024). Establishing standardization guidelines for finite-element optomechanical simulations of refractive laser surgeries: An application to photorefractive keratectomy. Translational Vision Science & Technology, 13(5), 11–11. https://doi.org/10.1167/tvst.13.5.11

Franceschelli, C., & Fantaci, B. (2020). Implementazione di un algoritmo elastostatico inverso con linearizzazione esatta per determinare la geometria vascolare scarica.

Fantaci, B., Calvo, B., Mesa, A. M., & Ortillés, A. (2025). Comparative evaluation of the mechanical properties of amniotic membranes for corneal grafting: Effects of cryopreservation, lyophilization, and dehydration. Journal of the Mechanical Behavior of Biomedical Materials, 107234. https://doi.org/10.1016/j.jmbbm.2025.107234

Fantaci, B., Rodríguez Matas, J. F., Squartecchia, V., Vavassori, L., & Calvo, B. (2025). Unraveling the impact of laser refractive surgery on corneal ectasia: An in silico study. Frontiers in Bioengineering and Biotechnology, 13, 1548539. https://doi.org/10.3389/fbioe.2025.1548539

Azim Paksa | Research Excellence | Best Researcher Award

Published on by Scientist Day

Dr. Azim Paksa | Research Excellence | Best Researcher Award

Dr. Azim Paksa, Shiraz University of Medical Sciences, Iran

Dr. Azim Paksa holds a Ph.D. in Medical Entomology and Vector Control from Tehran University of Medical Sciences, with over 15 years of academic and field experience in vector biology, insecticide resistance, and mosquito ecology. He has led numerous research projects focused on disease vectors such as Anopheles, Aedes, and Blattella germanica, and has published extensively in peer-reviewed ISI and ISC journals. His work includes gene sequencing contributions to GenBank, active participation in national congresses, and involvement in public health initiatives across Iran. Dr. Paksa is a member of the Iranian Societies of Medical Entomology and Parasitology and is skilled in molecular biology techniques, data analysis (SPSS), and scientific publishing.

Author Profile

orcid

🎓 Early Academic Pursuits

Dr. A. Paksa’s academic journey in the field of medical entomology began with a strong foundation at the Tehran University of Medical Sciences, where he pursued and successfully completed a Bachelor’s, Master’s, and Ph.D. in Medical Entomology and Vector Control. His early academic years were marked by a deep interest in public health and vector-borne diseases, which naturally progressed into a lifelong dedication to research and fieldwork. His Master’s thesis focused on detecting resistance mechanisms to organophosphate and carbamate insecticides in Blattella germanica (German cockroach) collected from Tehran hospitals. Later, during his Ph.D., he conducted an extensive study on the genetic diversity, Wolbachia infection, and ecological features of Aedes caspius and Aedes vexans, both of which are significant vectors for arboviruses in Iran. This early research demonstrated his capability in both laboratory and field settings, laying the groundwork for his future contributions to medical entomology and public health.

👨‍🔬 Professional Endeavors

Dr. Paksa has served in multiple academic, research, and public health capacities, working closely with Tehran University of Medical Sciences, Kashan University of Medical Sciences, and Hormozgan University of Medical Sciences, among others. As an executive director and principal collaborator, he has led and completed over a dozen major research projects addressing critical issues in entomology, such as insecticide resistance, vector identification, and ecological surveys of disease-carrying arthropods. In addition to field studies, Dr. Paksa has been an active member of organizing and scientific committees in several national conferences, including the Vector-Borne Diseases and Climate Change Congress and the Iranian National Congress on Medical Entomology, demonstrating his leadership in scientific community engagement.

🧪 Contributions and Research Focus

Dr. Paksa’s contributions to medical entomology are vast and multifaceted. He has authored numerous peer-reviewed ISI and ISC publications, covering topics from mosquito larvicidal properties of essential oils to biochemical resistance mechanisms in disease vectors. His research often combines molecular biology, field ecology, and applied public health, making it both academically rigorous and practically applicable.  His work has been instrumental in identifying and combating insecticide resistance in Anopheles stephensi and Blattella germanica, two vectors of significant public health concern. He has also made critical gene sequence deposits in GenBank, contributing to the global scientific repository with data from Iranian vector species. Dr. Paksa’s dedication to natural product-based insect control is notable—his investigations into the larvicidal effects of Iranian indigenous plant essential oils have opened new avenues in eco-friendly vector control strategies.

🏆 Accolades and Recognition

Throughout his career, Dr. Paksa has earned recognition for both the quality and breadth of his research. His presence in multiple national scientific conferences, both as a presenter and an organizing committee member, speaks to the high regard in which he is held by peers. He has served as a referee for the Journal of Arthropod-Borne Diseases and evaluated proposals and books for Zabol University of Medical Sciences, further reflecting his expertise and trustworthiness in scientific evaluation. Moreover, his active membership in the Iranian Society of Medical Entomology and Medical Parasitology for over a decade underscores his commitment to scientific collaboration and advancement within his specialty.

🌍 Impact and Influence

Dr. Paksa’s research has had a direct impact on vector control policies, hospital hygiene practices, and disease prevention strategies in Iran. His work on cockroach and mosquito resistance mechanisms has influenced how hospitals and municipalities approach pest control. Furthermore, his studies on head lice prevalence in schoolchildren and tick infestation in livestock have provided critical insights into zoonotic disease transmission and public health education. By combining field data with molecular insights, Dr. Paksa bridges the gap between lab-based science and real-world applications—making his work especially valuable to policy-makers, healthcare providers, and environmental health professionals.

🔬 Legacy and Future Contributions

With a solid foundation built on two decades of field experience, scientific research, and public health collaboration, Dr. Paksa is well-positioned to continue making influential contributions in the years ahead. His current projects focus on the molecular mechanisms of resistance in vector populations and the development of environmentally sustainable vector control strategies. In the future, Dr. Paksa aims to deepen international collaborations, contribute to global malaria and arboviral control efforts, and mentor the next generation of entomologists in Iran and beyond. His legacy will likely be remembered not only for his extensive publication record and field innovations but also for his dedication to improving public health through evidence-based research.

✍️Notable Publications

Molecular assay on detection of crimean congo hemorrhagic fever (CCHF) virus in ixodid ticks collected from livestock in slaughterhouse from south of Iran

Contributors: Salehi-Vaziri, M.; Vatandoost, H.; Sanei-Dehkordi, A.; Fazlalipour, M.; Pouriayevali, M.H.; Jalali, T.; Mohammadi, T.; Tavakoli, M.; Paksa, A.; Abadi, Y.S.

Journal: Arthropod-Borne Diseases

Year:2020

Biodiversity of mosquitoes (Diptera: Culicidae) with emphasis on potential arbovirus vectors in East Azerbaijan province, northwestern Iran

Contributors: Paksa, A.; Sedaghat, M.M.; Vatandoost, H.; Yaghoobi-Ershadi, M.R.; Moosa-Kazemi, S.H.; Hazratian, T.; Sanei-Dehkordi, A.; Oshaghi, M.A.

Journal: Arthropod-Borne Diseases

Year: 2019

Wild chive oil is an extremely effective larvicide against malaria mosquito vector Anopheles stephensi

Contributors: Sanei-Dehkordi, A.; Soleimani-Ahmadi, M.; Abadi, Y.S.; Paksa, A.
Journal: Tropical Medicine
Year: 2019